Item 2.02 Results of Operations and Financial Condition.

On February 6, 2020, ABIOMED, Inc. (the "Company," "we" or "us") issued a press release reporting our financial results for our third quarter ended December 31, 2019. A copy of the press release is set forth as Exhibit 99.1 and is incorporated herein by reference. The information contained in this report shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Securities Act of 1934, whether made before or after the date hereof and regardless of any general incorporation language in such filing, except as expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.



Exhibit   Description
99.1        Q3 FY2020 earnings press release dated February 6, 2020

--------------------------------------------------------------------------------


                                 Exhibit Index



Exhibit   Description
 99.1       Q3 FY2020 earnings press release dated February 6, 2020

  104     Cover Page Interactive Data File (embedded with the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses